The shrimp disease diagnostics market is anticipated to record a CAGR of 11.3% during the forecast period, up from USD 174.91 Million in 2021 to reach a valuation of USD 567.88 Mn by 2032.
| Attributes | Details |
|---|---|
| Global Shrimp Disease Diagnostics Market Value (2021) | USD 174.91 Million |
| Global Shrimp Disease Diagnostics Market Value (2032) | USD 567.88 Million |
| Global Shrimp Disease Diagnostics Market CAGR (2022 to 2032) | 11.3% |
Sales of shrimps disease diagnostics system are expected to rise due to growing demand for shrimp farming, as well as developments in disease detection molecular diagnostics techniques. In addition to this, demand for shrimp disease diagnostics system is anticipated to rise due to the overall growth in seafood demand and the development of the disease diagnostics market share.
Increasing global production of shrimps is also projected to contribute to the growth of the shrimp disease diagnostics market share.
Due to the multiple benefits, the demand for shrimp disease diagnostics system is anticipated to grow, and the idea of biosecurity application to shrimp farming would also see a significant increase in order to reduce losses in shrimp production due to disease prevalence. As a result, sales of shrimp disease diagnostics system is anticipated to rise.
Some of the key shrimp disease diagnostics market trends promoting the demand for shrimp disease diagnostics system include technological advancement in the field of aquaculture disease diagnosis.
Explore FMI!
Book a free demo
Growing demand for shrimps for human consumption and nutrient purpose is the major favour expected to boost up the sales of shrimp disease diagnostics system and the growth of shrimp disease diagnostics market. Rising demand for freshwater and marine shrimp farming is the major driving factor of the disease diagnostics market share.
Shrimp farming is gaining popularity for production of shrimp for human consumption. Thus, the demand for shrimp disease diagnostics system is also rising. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
Disease problems in shrimp production are poorly understood and diagnosed. This factor propels the demand for shrimp disease diagnostics system to counter all the disease in shrimps. As a result, the sales of shrimp disease diagnostics system is also anticipated to grow during the forecast period.
Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge, which is anticipated to affect the sales of shrimp disease diagnostics system.
There is no therapeutic option available for viral diseases, and the only option available is to detect and avoid the pathogen entry into culture systems. Therefore, the only option left is shrimps disease diagnostics.
This is also a major factor that is anticipated to augment the demand for shrimp disease diagnostics system and support the growth of disease diagnostics market share.
DNA based diagnostic tools such as PCR are used to test. Diagnosis tools and technologies are gaining demand for shrimp disease diagnostics system for quick and effective diagnosis of shrimp diseases to manage the disease outbreaks. Assay based kits and rapid test kits are available for the shrimp disease diagnostic market.
The Asia Pacific is expected to dominate the shrimp disease diagnostics market as high production rate in China and India. Sales of shrimp disease diagnostics system are increasing on the global level especially in Asia Pacific countries such as India and China. About 30% of farmed shrimp is produced in Asia, particularly in China and Indonesia.
Shrimps disease diagnostics market is expected to represent prominent growth in the countries such as the United States, Japan and Western Europe.
Growing consumption of shrimps in the food and strict regulatory policies regarding food safety in the countries such as the U.S. and Japan are expected to boost up the sales of shrimps disease diagnostics system and the growth of the shrimp disease diagnostics market.
Key players in global shrimps disease diagnostics market are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies and others.
Recent Developments
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 11.3% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors and trends, Pricing Analysis |
| Segments covered | Reagent Kits, Disease type, End user, region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | HiMedia Laboratories; Speedy Assay Sdn Bhd; REAGEN LLC; FUJIKURA KASEI CO.; LTD.; GeneReach Biotechnology Corp.; Thermo Fisher Scientific; Lab - Ind Resource Sdn Bhd.; AquaBounty Technologies, Inc.; GeneReach Biotechnology Corp.; pop bio; SUREBIO; Auro Biotechnologies |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The global shrimp disease diagnostics market is likely to register a CAGR of 11.3% during the forecast period.
Key players holding substantial global shrimp disease diagnostics market share include HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd., AquaBounty Technologies, Inc., GeneReach Biotechnology Corp., pop bio, SUREBIO, Auro Biotechnologies.
As per the analysis, the global shrimp disease diagnostics market share is likely to be US$ 567.88 Mn by 2032.
Demand for shrimp disease diagnostics system is likely to rise due to growing demand for shrimp farming, as well as developments in disease detection molecular diagnostics techniques.
Shrimps Disease Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
